Bone News and Research

RSS

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Newly published research provides preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease (GvHD), a potentially lethal complication of bone marrow stem cell (BMSC) transplantation.

14 Nov 2017

Simple color-changing test to detect fluoride in drinking water could prevent skeletal fluorosis

A simple colour-changing test to detect fluoride in drinking water, devised by researchers at the University of Bath, could in the future prevent the crippling bone disease, skeletal fluorosis, in developing countries such as India and Tanzania.

14 Nov 2017

Review shows significant racial and ethnic disparities in firearms-related eye trauma

A review of patients who suffered firearms-related eye trauma shows significant disparities in race, location, and circumstance, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

13 Nov 2017

Air pollution may exacerbate osteoporosis

Based on a study of nine million people, researchers at Columbia University's Mailman School of Public Health People report that people living amidst high levels of air pollution are more likely to suffer bone fractures from osteoporosis than those living in areas with less pollution.

10 Nov 2017

Scientific Statement captures evolving understanding of microvascular complications related to diabetes

The Endocrine Society issued a new Scientific Statement today examining how diabetes damages the body's smallest blood vessels as well as how the condition affects the body's natural repair processes designed to protect the eyes, kidneys, nerves and other organs.

9 Nov 2017

Women with ER-positive breast cancer face disease recurrence risk years after treatment ends

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.

9 Nov 2017

Orthocell earns CE Mark approval for CelGro collagen medical device

Regenerative medicine company Orthocell Limited is pleased to announce receipt of European regulatory approval (CE Mark) for its CelGro collagen medical device.

8 Nov 2017

German scientists develop new nuclear medicine test to identify kidney transplant infection

German scientists have developed a novel nuclear medicine test that can determine whether a kidney transplant patient has developed infection in the transplanted tissue.

8 Nov 2017

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes, or fat cells, can absorb and metabolize the chemotherapeutic agent daunorubicin, reducing the effectiveness of the drug and potentially contributing to poorer treatment outcomes.

8 Nov 2017

Vitamin D deficiency linked to decreased likelihood of successful pregnancy in women with PCOS

Vitamin D may play a key role in helping some women seeking treatment for polycystic ovary syndrome (PCOS)-related infertility get pregnant.

7 Nov 2017

Penn Medicine to conduct Northeast’s first clinical trial of uterine transplants

Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.

7 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Most teas contain safe amounts of fluoride, UF study finds

If you drink tea, you can rest assured about your children's teeth or your adult bones, now that a University of Florida research team has found that most teas contain safe amounts of fluoride.

7 Nov 2017

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with Michael Keller, MD from Children's National Health System in Washington, DC, have been awarded $4.8 million by the California Institute for Regenerative Medicine to study the use of a new T-cell therapy to help fight active viral infections in children with severe immune deficiencies.

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

MRI scans of healthy military recruits reveal sacroiliac joint damage that mimics axial spondyloarthritis

The magnetic resonance imaging scans of healthy military recruits showed sacroiliac joint damage similar to that found in axial spondyloarthritis after just six weeks of intensive physical training, reinforcing the importance of exercising caution when interpreting MRI results, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

$Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women$

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Women who took a drug holiday (temporary or permanent discontinuation of a medicine) from using bisphosphonates for more than two years have a significantly higher risk of a hip fracture compared to others who continued their treatment, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Study points to novel, effective treatment for CKD patients with metabolic acidosis

Patients with chronic kidney disease (CKD) often develop a condition called metabolic acidosis, which is characterized by an imbalance in acid production relative to excretion.

6 Nov 2017

Bone News and Research

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Simple color-changing test to detect fluoride in drinking water could prevent skeletal fluorosis

Review shows significant racial and ethnic disparities in firearms-related eye trauma

Air pollution may exacerbate osteoporosis

Scientific Statement captures evolving understanding of microvascular complications related to diabetes

Women with ER-positive breast cancer face disease recurrence risk years after treatment ends

Orthocell earns CE Mark approval for CelGro collagen medical device

German scientists develop new nuclear medicine test to identify kidney transplant infection

Adipocytes may reduce effectiveness of chemotherapeutic drug

Vitamin D deficiency linked to decreased likelihood of successful pregnancy in women with PCOS

Penn Medicine to conduct Northeast’s first clinical trial of uterine transplants

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Most teas contain safe amounts of fluoride, UF study finds

Researchers to test use of ‘viral specific’ T-cells to target toxic viruses in children

FDA grants approval to first treatment for rare blood cancer

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

FDA approves new drug Zelboraf for Erdheim-Chester disease

MRI scans of healthy military recruits reveal sacroiliac joint damage that mimics axial spondyloarthritis

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Study points to novel, effective treatment for CKD patients with metabolic acidosis

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News